Member contribution Expert Insights
Expert Insights, Cardiology, Cardiovascular conditions

The ISCHEMIA trial

While its significance went relatively unnoticed in the UK media, it generated controversial headlines elsewhere in the world. However its results will undoubtedly influence future clinical practice guidelines.
Published
Go to the profile of Stephen Dorman
Stephen Dorman
Go to the profile of Simon Grime

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date
Register

Existing members Sign in

Sorry, we need to confirm your details before you can access this content.

If you have just signed up to OnMedica, you are seeing this message because we couldn’t automatically verify that you are a practising doctor in the UK. Please check your email inbox as we may need a few more details to validate your OnMedica membership. If you haven’t received an email from us or you need assistance, please contact customer.services@onmedica.com.

Go to the profile of Stephen Dorman
Stephen Dorman
I am a consultant cardiologist at the Bristol Heart Institute where I specialise in coronary and structural intervention. I am the clinical lead for the coronary intervention and transcatheter aortic valve implantation (TAVI) services at the BHI. I undertook my interventional fellowship at Hopital Bichat in Paris , before moving to Swansea and then Bristol and have been a consultant for 10 years.

You may also be interested in...